Accretion Pharmaceuticals Limited (NSEI: ACCPL)
Health Care · Pharmaceuticals · IN
Rs190.50
+0.24% today · +222.9% 1Y
Accretion Pharmaceuticals Limited (NSEI: ACCPL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $22.15M.
Over the last twelve months the share price has gained 222.9%, trading between 53.80 and 190.05.
Tweenvest scores Accretion Pharmaceuticals Limited across four factors: quality 58/100, value 29/100. Its strongest factor is quality.
ACCPL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.15M
- Revenue (TTM)
- $9.56M
- P/E
- 21.10
- EPS
- 9.03
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs190.05
- 52-week low
- Rs53.80
- Avg volume (3M)
- —
- Shares outstanding
- 11.12M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.